A Phase 1, Randomized, Open-Label Study to Assess the Bioequivalence of Trofinetide as a Ready-to-Use Oral Solution and Constituted Powder for Oral Solution in Healthy Adults

Adis journals on behalf of; Mona Darwish; Amy Yamamoto; Yvonne Holmes Adegbenle; Ravi Tejwani; Yonghua Chen; Rene Nunez-Disla; James M. Youakim; Sanjeev Pathak

doi:10.6084/m9.figshare.30911252

A Phase 1, Randomized, Open-Label Study to Assess the Bioequivalence of Trofinetide as a Ready-to-Use Oral Solution and Constituted Powder for Oral Solution in Healthy Adults

Figshare 2026 Open access

Read full text

Authors: Adis journals on behalf of, Mona Darwish, Amy Yamamoto, Yvonne Holmes Adegbenle, Ravi Tejwani, Yonghua Chen, Rene Nunez-Disla, James M. Youakim, Sanjeev Pathak

DOI: 10.6084/m9.figshare.30911252

Cited by: 0

Abstract

Article full textThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).

Fields of Study & Subjects

Pharmaceutical studies and practices Statistical Methods in Clinical Trials Biosimilars and Bioanalytical Methods

Publication details

Journal / source: Figshare
Publication date: 1 January 2026